Concepedia

Robyn Shea

RS

9

Publications

772

Citations

9

H-Index

1993

Active since

Affiliations

Institute of Cancer Research(Current)

Royal Marsden NHS Foundation Trust

The Francis Crick Institute

University College London

London Cancer

Robyn Shea is an author at Institute of Cancer Research specializing in medicine, vaccination, and vaccine efficacy.

ORCID

Top concepts

Publications per year

1993–2022

9

Publications

9

Adaptive immunity and neutralizing antibodies against SARS-CoV-2 variants of concern following vaccination in patients with cancer: the CAPTURE study

Annika Fendler, Scott T.C. Shepherd, Lewis Au et al. · Nature Cancer · 2021 · 177 citations · Full text

Response to first vaccination against SARS-CoV-2 in patients with multiple myeloma

Sarah Bird, Aikaterini Panopoulou, Robyn Shea et al. · The Lancet Haematology · 2021 · 136 citations · Full text

, , +6

Cathepsin D expression detected by immunohistochemistry has independent prognostic value in axillary node-negative breast cancer.

Jorma Isola, Stephen Weitz, Tapio Visakorpi et al. · Journal of Clinical Oncology · 1993 · 114 citations

N-(3-Cyano-4,5,6,7-tetrahydro-1-benzothien-2-yl)amides as potent, selective, inhibitors of JNK2 and JNK3

Richard Angell, Francis Atkinson, Murray J. B. Brown et al. · Bioorganic & Medicinal Chemistry Letters · 2006 · 90 citations · Full text

, , +4

Functional antibody and T cell immunity following SARS-CoV-2 infection, including by variants of concern, in patients with cancer: the CAPTURE study

Annika Fendler, Lewis Au, Scott T.C. Shepherd et al. · Nature Cancer · 2021 · 88 citations · Full text

Rows per page

1–5 of 9